{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Managing the Effects of Cardiac Cachexia

Purpose of Activity

To provide information on cachexia in cardiac disease.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Identify the definition, pathophysiology, assessment, and diagnostic workup of cachexia specific to cardiac disease.
  2. Select pharmacological and nonpharmacological interventions for the patient with congestive heart failure (CHF)–related cachexia.
Price: $21.95


  • ANCC 2.3 CH
  • DC - BON 2.3 CH
  • FL - BON 2.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.

Test Code: JHPN0214
Published: Feb 2014
Expires: 3/5/2021
Passing Score: 13/18 (72%)
Authors: Heather Carlson, ANP-BC, ACHPN; Constance M. Dahlin, MSN, ANP-BC, ACHPN, FPCN, FAAN